<p>Psychedelics are a hot topic, and a drug called ibogaine is receiving attention after a recent shoutout from U.S. President Donald Trump. University of Calgary psychedelics researcher Leah Mayo explains what ibogaine is, and why limited high-quality research has her hesitant to recommend it.</p><p><br></p><p>For transcripts of The Dose, please visit:&nbsp;<a href="https://www.cbc.ca/radio/podcastnews/the-dose-transcripts-listen-1.6732281" rel="noopener noreferrer" target="_blank">lnk.to/dose-transcripts</a>. Transcripts of each episode will be made available by the next workday. For more episodes of this podcast,&nbsp;<a href="https://podcasts.apple.com/us/podcast/the-dose/id1498259551" rel="noopener noreferrer" target="_blank">click this link.</a></p>